
GC63874
NSC 107512
Also known as 4-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-N'-hydroxypyrrolo[2,3-d]pyrimidine-5-carboximidamide
NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9)· NSC 107512 is a class of sangivamycin-like molecules (SLM)· NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors
ChemicalCAS22242-89-3MW324.29FormulaC12H16N6O5
- CAS number
- 22242-89-3
- Molecular weight
- 324.29
- Formula
- C12H16N6O5
- Solubility
- DMSO : 170 mg/mL (524·22 mM; Need ultrasonic)
- InChIKey
- UJSNJRHHJZOXPZ-UHFFFAOYSA-N
- Catalogue number
- GC63874
- Brand
- GLPBIO
Computed properties PubChem CID 5369182 · XLogP -2.2 · TPSA 185 Ų · H-bond donors 6
- XLogP
- -2.2
- TPSA
- 185 Ų
- H-bond donors
- 6
- H-bond acceptors
- 9
- Rotatable bonds
- 3
- Heavy atoms
- 23
SMILES C1=C(C2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N)/C(=N/O)/N
Computed descriptors from PubChem (CID 5369182), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il